Abstract
The dataset represented in this article is referred to by the review article entitled “Topical drug delivery: history, percutaneous absorption, and product development” (MS Roberts et al., 2021) [1]. The dataset contains maximal flux (Jmax), and permeability coefficient (kp) values collated from In Vitro human skin Permeation Test (IVPT) reports published to date for various drugs, xenobiotics, and other solutes applied to human epidermis from aqueous solutions. Also included are each solute's physicochemical properties and the experimental conditions, such as temperature, skin thickness, and skin integrity, under which the data was generated. This database is limited to diluted or saturated aqueous solutions of solutes applied on human epidermal membranes or isolated stratum corneum in large volumes so that there was minimal change in the donor phase concentration. Included in this paper are univariate Quantitative Structure-epidermal Permeability Relationships (QSPR) in which the solute epidermal permeation parameters (kp, and Jmax) are related to potential individual solute physicochemical properties, such as molecular weight (MW), log octanol-water partition coefficient (log P), melting point (MP), hydrogen bonding (acceptor - Ha, donor – Hd), by scatter plots. This data was used in the associated review article to externally validate existing QSPR regression equations used to forecast the kp and Jmax for new therapeutic agents and chemicals. The data may also be useful in developing new QSPRs that may aid in: (1) drug choice and (2) product design for both topical and transdermal delivery, as well as (3) characterizing the potential skin exposure of hazardous substances.
Keywords: Percutaneous absorption, maximum flux, epidermal permeability, in vitro human skin penetration test (IVPT), quantitative structure-property relationship (QSPR), xenobiotics, solute physicochemical properties, topical delivery systems, transdermal delivery, toxicology
Specifications Table
| Subject | Pharmaceutical Sciences |
| Specific subject area | Determination of human skin absorption parameters based on in vitro permeation test (IVPT) data |
| Type of data | Table (in Mendeley repository) Figures Text file |
| How data were acquired | Performed literature search, extracted the data using DataThief III wherever relevant from the published reports, collected experimental result parameters for solutes along with their physicochemical properties, and tabulated in Microsoft Excel. |
| Data format | Raw Analyzed |
| Parameters for data collection | Permeability, steady-state flux, maximum flux, stratum corneum solubility, stratum corneum partition coefficient, in vitro absorption profiles through human skin |
| Description of data collection | Solute experimental in vitro human skin permeation data were collected from published articles, thesis, reports, and web documents. Corresponding compound physicochemical properties were considered from Drugbank, Chemspider, Pubchem, and Chemical book. |
| Data source location | Institution: The University of Queensland at Translational Research Institute City: Brisbane, Queensland Country: Australia |
| Data accessibility | The tabular database is available in therepository name: Mendeley Data Data identification number: 10.17632/8bs7hb2wj2.1 Direct URL to data:https://data.mendeley.com/datasets/8bs7hb2wj2/1 |
| Related research article | [1] Roberts MS et al. Topical drug delivery: history, percutaneous absorption, and product development. Adv. Drug Deliv. Rev. 177 (2021): 113929. |
Value of the Data
-
•
The collected dataset can be used to explore the Quantitative drug Structure-epidermal Permeation Relationships (QSPR) that underpin drug choice and formulation design for potential topical and transdermal delivery products and potential skin exposure and toxicity for xenobiotics.
-
•
Such relationships can also be used to assist drug discovery teams in designing and extracting chemicals, pharmaceutical scientists in designing topical or transdermal delivery products, regulators in assessing topical or transdermal delivery products efficacy and safety properties, toxicologists in evaluating xenobiotic exposure, and academic scientists interested in percutaneous absorption.
-
•
The resulting QSPR relationships are also useful in predicting drug behavior in the skin and the body by physiologically based pharmacokinetic (PBPK) and toxicokinetic (PBTK) modelling, including in predicting dermal and systemic exposure with pharmacokinetic software such as the Simcyp® derived MechDermA model, the Gastroplus® derived Transdermal Compartmental Absorption & Transit (TCAT™) model and toxicokinetic software such as EPA's Stochastic Human Exposure and Dose Simulation (SHEDS), U.S. EPA. Swimmer Exposure Assessment Model (SWIMODEL), RISKOFDERM, EUROPOEM II, DREAM.
-
•
This is the first major update of our Magnusson et al. [2] database that has been cited 295 times in Google Scholar to date (03/Apr/2022).
-
•
This database could provide insights into validating the application range and limitations of various QSPR models such as Potts and Guy [3], Moss and Cronin [4,5], Magnusson et al. [2], Milewski-Stinchcombe [6], and Roberts-Sloan [7], [8], [9], [10] for Jmax and kp [11,12].
1. Data Description
The collected constrained dataset as shown in Table 1 [13] contains 476 records of 145 drugs, chemicals, and xenobiotics applied to in vitro human epidermal membranes from aqueous solutions either diluted or saturated in infinite dose amounts (constant concentration). This is the recent dataset updated from the 1960s to 2021 which is an extension of Magnusson et al. [2] aqueous training set (87 records of 64 solutes from 21 published reports). This new extended dataset contains 389 new records of 116 solutes from 47 published reports. There are few compounds in common between the original Magnusson et al. [2] dataset and this extended dataset making the count as 145 solutes. This database contains both epidermal permeability coefficients (kp) used in many studies as the key measure for solute permeation through the skin [3], [4], [5] and the lesser-used maximal flux (Jmax) [1,[6], [7], [8], [9], [10],14] reported or derived from steady-state epidermal flux (Jss) from aqueous solutions after adjustment for solute concentration effects. A key focus in the associated review [1] is Jmax because, from a clinical or toxicological perspective, it is a more meaningful parameter than kp [6], [7], [8], [9] in that it characterizes the maximum steady-state exposure expected for drugs, chemicals, and xenobiotics. This exposure, defined by the maximum dose deliverable over a time period after application [2,6], equals the saturated compound flux (Jsat) from a saturated thermodynamically stable system, with solubility Sv that does not affect epidermal integrity:
| (1) |
where Ssc and Sv are the solute's solubility in the SC and vehicle, respectively, Dsc is a solute's diffusion coefficient over an SC pathlength hsc, Ksc is the solute's stratum corneum to vehicle partition coefficient, where Ksc= Ssc/ Sv, and kp is the epidermal permeability coefficient, where kp=KscDsc/hsc. The significance of Jmax is evident in the work of Higuchi [15]. In principle, higher fluxes may be achieved from supersaturated solutions as a result of their transient higher solubility in those solutions [16] and can be facilitated through the evaporation of topical products applied to the skin as a thin film.
The overall database possesses wide distribution of compound physicochemical properties and permeation parameters i.e., molecular weight (MW) ranging from 18 to 504, lipophilicity, defined as the logarithm of the octanol-water partition coefficient (log P or log Ko/w) ranging from -4.6 to 7.7, melting point (MP) in Kelvin ranging from 147 to 573, log aqueous solubility (log Saq) ranging from -10 to 1.24 mol/mL, log octanol solubility (log Soc) ranging from -8 to 0.88, hydrogen bond donor (Hd) ranging from 0 to 11, hydrogen bond acceptor (Ha) ranging from 0 to 16, molecular volume (MV) ranging from 17 to 434 cm3 per mole, experimental temperature (oK) ranging from 295 to 312, epidermal thickness (mm) from 0.01 to 0.128, epidermal permeability coefficients (log kp, cm/h) ranging from -5.52 to -0.08 and epidermal maximum flux (log Jmax, mol/cm2/h) ranging from -12.99 to -3.88. Here Octanol solubility was calculated as Soc = Saq * Ko/w and molecular volume (MV) was estimated using Fedors’ (1974) group contribution method [17] or obtained from the ChemSpider [18] database.
The frequency distribution of these solute physicochemical and skin permeation properties, along with their inter-relationships were shown comprehensively using scatter-matrix plots as shown in Fig. 1. The same data in Fig. 1 was represented by considering a third physicochemical property as a covariate to analyze the relationship between skin permeation parameter and compound property as shown in Fig. 2 and Fig. 3 for log Jmax and log kp respectively.
Fig. 1.
Frequency distribution of various solute physicochemical (MW, log P, MP, log Saq, log Soc, Hd, Ha, MV) and skin permeation properties (log kp and log Jmax), along with their inter-relationships
Fig. 2.
Interrelationship of Jmax for human epidermal permeation of solutes from aqueous solutions with solute physicochemical properties: Plot of A) log Jmax vs. MW showing polarity as a covariate, B) log Jmax vs. log P showing MW as a covariate, C) log Jmax vs. MP showing MW as a covariate, D) log Jmax vs. log Saq showing MP as a covariate, and E) log Jmax vs. log Soc showing MP as a covariate.
Fig. 3.
Interrelationship of kp for human epidermal permeation of solutes from aqueous solutions with solute physicochemical properties: Plot of A) log kp vs. MW showing polarity as a covariate, B) log kp vs. log P showing MW as a covariate, C) log kp vs. MP showing MW as a covariate, D) log kp vs. log Saq showing MP as a covariate, and E) log kp vs. log Soc showing MP as a covariate.
2. Experimental Design, Materials and Methods
To generate the database shown in Table 1 [13], a comprehensive search was performed on Google, PubMed, Google Scholar, and other scientific publishing sites using the keywords: “in vitro”, “human skin”, “permeation”, “penetration”, “permeability”, “aqueous solutions”, “saturated systems” and “flux”. Using some inclusion criteria, various skin permeation-related data parameters mainly kp, Jss, and Jmax were collected from these published reports. Those criteria were:
-
•
All these reports were research publications, scientific reports, university-related theses, and personal communications that are publicly available and easily accessible.
-
•
Most of these data were primarily from publications and were referenced accordingly in the reference column in Table 1 as author and year.
-
•
kp, Jmax were extracted directly if present or else calculated from kp, and saturated solubility or Jss and experimental concentration using Eq.1 and making sure the units for kp and Jmax were cm/h and mol/cm2/h respectively.
-
•
Only the reports with undamaged skin were considered and included their skin integrity tests performed (electrical conductivity, transepidermal water loss (TEWL), tritiated water permeability, physical examination, sucrose transport, etc.,) along with their skin selection criteria (resistance measurements, flux comparisons before and after the experiments and other methods) in this database.
-
•
Only human epidermal and isolated stratum corneum membranes were considered to account for the barrier resistance and data uniformity assuming very minimal resistance offered by the viable epidermis.
-
•
Only data from aqueous solutions and buffers used as a vehicle were included and the alcoholic or non-aqueous co-solvents data were ignored.
-
•Only unionized solutes with fraction unionized (fui) > 0.9 were selected in this database based on Eq. 2 as shown below:
(2)
Moreover, Jmax was calculated using Eq. 1, considering the same aqueous solubility as in the buffer applied in in vitro experiments, and assuming no ionization occurred at skin or experimental pH conditions of 5.5 to 7.4 based on the solute pKa.
Thus, considering these criteria, the resulted data were tabulated in Table 1 [13] by collecting various solute physicochemical properties from Chemspider [18], PubChem [19], ChemicalBook [20], and DrugBank [21] along with kp, and Jmax values:
-
•
Compound name
-
•
Chemical Abstract Service (CAS) number
-
•
Molecular weight (MW) in Daltons
-
•
Octanol-water partition coefficient (Log P or Log ko/w)
-
•
Melting Point (MP) in Kelvin
-
•
Aqueous solubility represented as Log Saq in the units of mol/mL
-
•
Octanol solubility represented as Log Soc in the units of mol/mL
-
•
Hydrogen Donor (Hd)
-
•
Hydrogen Acceptor (Ha)
-
•
Molecular Volume (MV) in the units of cm3 per mol
-
•
Experimental temperature (Texp) in the units of Kelvin
-
•
Skin thickness in mm: 0.01 and 0.075 mm indicates isolated stratum corneum thickness, 0.1 and 0.128 mm indicate heat separated epidermis membrane.
-
•
Skin integrity test column was captured wherever reported
-
•
Skin selection criteria were captured wherever reported
-
•
Skin permeability in cm/h represented as Log kp
-
•
Maximum flux in mol/cm2/h represented as Log Jmax
-
•
Reference column was labeled in the form of author and year from the published report
If the parameters were unknown, the respective cells are empty in Table 1 [13]. Here based on the applied donor solution whether it is non-saturated and saturated or neat liquid, the data was classified as t and t* respectively in the column name called ‘set’. All this dataset was tabulated using Microsoft excel software 2016. While making the relationships as shown in Fig. 2 and Fig. 3, the data was sorted using a filter application and arranged accordingly. The main application of this new dataset (n=389) is validating the well-known Jmax models of Magnusson et al. [2], Milewski-Stinchcombe [6], Abbott et al. [14], and Roberts-Sloan [7,9] using the Magnusson et al. [2] aqueous dataset (n=87) as a testing set. This was shown in Fig. 5 in the co-submitted paper of MS Roberts et al. [1], which also provided updated regression equations for each best-fit model along with the model diagnostic parameters such as adjusted correlation coefficient (Radj2), root means square error (RMSE), and Akaike information criteria (AIC). These statistical graphs are shown in Fig. 1 as scatter matrix plots generated using Statistica® version 13 (TIBCO® Data Science). Fig. 2 and Fig. 3 were plotted using GraphPad Prism® version 9.
Table 1In vitro human epidermal Permeation Test (IVPT) dataset of various drugs, xenobiotics, and other solutes detailing their physicochemical properties, experimental conditions, and their human epidermal permeation parameters from aqueous solutions (kp and Jmax) [13]. The contents of this very large table are located in the Mendeley Data Repository, Data identification number: 10.17632/8bs7hb2wj2.1 and the data can be accessed by Direct URL: https://data.mendeley.com/datasets/8bs7hb2wj2/1. Values highlighted in green (or the data records from row 1 to 87) are the Magnusson aqueous training dataset containing 87 data records of 64 compounds whereas those in orange (or the records from row 88 to 476) are the 389 data records of 116 solutes all other solutes defined in this new database and used for external validation in [1]. Together, the combined dataset contains a total of 476 data records of 145 solutes and has a listing of:
aMW-molecular weight (Dalton), blog Kow or log P – logarithm of octanol-water partition coefficient, cMP- melting point in Kelvin, dLog Saq- logarithm of aqueous solubility (mol/mL), eLog Soc- logarithm of octanol solubility (mol/mL), fHd- hydrogen donor, gHa- hydrogen acceptor, hMV- molecular volume (cm3 per mol), iTexp- experimental temperature, jskin thickness in mm: 0.01 and 0.075 mm indicates isolated stratum corneum thickness, 0.1 and 0.128 mm indicates heat separated epidermis membrane, lkp-skin permeability in cm/h and mlog Jmax-logarithm of maximum flux (mol/cm2/h).
Ethics Statement
No animal or human ethics are involved.
CRediT Author Statement
Hanumanth Srikanth Cheruvu: Data collection, Analysis, Methodology, Software, Manuscript writing; Xin Liu: Data verification, Manuscript proofreading; Jeffrey E Grice: Data verification, manuscript editing; Michael S. Roberts: Conceptualization, Supervision, Reviewing, and editing.
Declaration of Competing Interest
Hanumanth Srikanth Cheruvu was supported by an Australian Government Research Training Program (International) scholarship awarded by the University of Queensland. Michael S. Roberts was the recipient of a National Health and Medical Research Council of Australia Fellowship (#1107356). The authors declare that they have no known competing financial interests or personal relationships, which have or could be perceived to have influenced the work reported in this article.
Acknowledgments
The authors are thankful to the Canadian research intern students Tyler Scott and Thomas Yi from the University of Manitoba who contributed partly to the dataset preparation. This research was carried out at the Translational Research Institute, Woolloongabba, QLD 4102, Australia. The Translational Research Institute is supported by a grant from the Australian Government.
Data Availability
References
- 1.Roberts M.S., Cheruvu H.S., Mangion S.E., Alinaghi A., Benson H.A., Mohammed Y., Holmes A., van der Hoek J., Pastore M., Grice J.E. Topical drug delivery: History, percutaneous absorption, and product development. Adv. Drug. Deliv. Rev. 2021;177 doi: 10.1016/j.addr.2021.113929. [DOI] [PubMed] [Google Scholar]
- 2.Magnusson B.M., Anissimov Y.G., Cross S.E., Roberts M.S. Molecular size as the main determinant of solute maximum flux across the skin. J. Invest. Dermatol. 2004;122:993–999. doi: 10.1111/j.0022-202X.2004.22413.x. [DOI] [PubMed] [Google Scholar]
- 3.Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 1992;9:663–669. doi: 10.1023/a:1015810312465. [DOI] [PubMed] [Google Scholar]
- 4.Moss G.P., Cronin M.T. Quantitative structure–permeability relationships for percutaneous absorption: re-analysis of steroid data. Int. J. Pharm. 2002;238:105–109. doi: 10.1016/s0378-5173(02)00057-1. [DOI] [PubMed] [Google Scholar]
- 5.Cronin M., Dearden J., Moss G., Murray-Dickson G. Investigation of the mechanism of flux across human skin in vitro by quantitative structure–permeability relationships. Eur. J. Pharm. Sci. 1999;7:325–330. doi: 10.1016/s0928-0987(98)00041-4. [DOI] [PubMed] [Google Scholar]
- 6.Milewski M., Stinchcomb A.L. Estimation of maximum transdermal flux of nonionized xenobiotics from basic physicochemical determinants. Mol. Pharmaceutics. 2012;9:2111–2120. doi: 10.1021/mp300146m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Juntunen J., Majumdar S., Sloan K.B. The effect of water solubility of solutes on their flux through human skin in vitro: A prodrug database integrated into the extended Flynn database. Int. J. Pharm. 2008;351:92–103. doi: 10.1016/j.ijpharm.2007.09.034. [DOI] [PubMed] [Google Scholar]
- 8.Thomas J., Majumdar S., Wasdo S., Majumdar A., Sloan K.B. The effect of water solubility of solutes on their flux through human skin in vitro: an extended Flynn database fitted to the Roberts–Sloan equation. Int. J. Pharm. 2007;339:157–167. doi: 10.1016/j.ijpharm.2007.02.031. [DOI] [PubMed] [Google Scholar]
- 9.Majumdar S., Thomas J., Wasdo S., Sloan K.B. The effect of water solubility of solutes on their flux through human skin in vitro. Int. J. Pharm. 2007;329:25–36. doi: 10.1016/j.ijpharm.2006.08.015. [DOI] [PubMed] [Google Scholar]
- 10.Roberts W.J., Sloan K.B. Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts–Guy approach. J. Pharm. Sci. 1999;88:515–522. doi: 10.1021/js980419b. [DOI] [PubMed] [Google Scholar]
- 11.H.S. Cheruvu, Modeling approaches to predict human skin absorption of drugs and other chemicals, The University of Queensland, Ph.D. thesis (2021) 248.
- 12.Cheruvu H.S., Liu X., Grice J.E., Roberts M.S. Modeling percutaneous absorption for successful drug discovery and development. Expert Opin. Drug Discovery. 2020;15:1181–1198. doi: 10.1080/17460441.2020.1781085. [DOI] [PubMed] [Google Scholar]
- 13.Cheruvu H.S. An updated skin permeation database of compounds applied as aqueous solutions in in vitro. Mendeley Data. 2022;V1 doi: 10.17632/8bs7hb2wj2.1. [DOI] [Google Scholar]
- 14.Abbott S., Hansen C.M., Yamamoto H., Valpey R.S. Hansen-Solubility.com; 2013. Hansen Solubility Parameters in Practice, in: S. Abbott (Ed.) [Google Scholar]
- 15.Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 1960;11:85–97. [Google Scholar]
- 16.Scheuplein R.J. Mechanism of percutaneous adsorption: I. Routes of penetration and the influence of solubility. J. Invest. Dermatol. 1965;45:334–346. doi: 10.1038/jid.1965.140. [DOI] [PubMed] [Google Scholar]
- 17.Fedors R.F. A method for estimating both the solubility parameters and molar volumes of liquids. Polymer Engineering & Science. 1974;14:147–154. [Google Scholar]
- 18.Pence H.E., Williams A. in, ACS Publications; 2010. ChemSpider: an online chemical information resource. [Google Scholar]
- 19.Kim S., Chen J., Cheng T., Gindulyte A., He J., He S., Li Q., Shoemaker B.A., Thiessen P.A., Yu B. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019;47:D1102–D1109. doi: 10.1093/nar/gky1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.ChemicalBook, https://www.chemicalbook.com/, (2006).
- 21.Wishart D.S., Knox C., Guo A.C., Shrivastava S., Hassanali M., Stothard P., Chang Z., Woolsey J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668–D672. doi: 10.1093/nar/gkj067. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



